Clinical Trial Update: Prediction of Severity of Liver Disease by a 13C Octanoate Breath Test (OBT) [Phase 2]

View source ↗

Summary

Phase 2 study evaluating a 13C octanoate breath test to predict liver disease severity in metabolic syndrome and nonalcoholic fatty liver disease; the trial was…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome
• Nonalcoholic Fatty Liver Disease

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Metabolic Syndrome, Nonalcoholic Fatty Liver Disease | Phase 2 | Status: TERMINATED | Results posted: 2015-07-28